Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma
Sunday, April 7, 2013 - 22:30
in Health & Medicine
Vemurafenib-resistant tumors in patients with melanoma showed reduced growth after cessation of treatment, and in animal models, drug resistance was prevented by intermittent treatment, according to new data.